Control of gene expression in viruses and protozoan parasites by antisense oligonucleotides

Parasitology

Volumn 114, Issue SUPPL. 1, 1997, Pages

  Toulme J J ^a   Bourget, C ^a   Compagno, D ^a   Yurchenko, L ^a,b  

^a INSERM   (France)

^b INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

Author keywords

Antisense oligonucleotides; Gene expression; Mini exon sequence; Translation; Trypanosomatid; Virus

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE;

ANTIVIRAL ACTIVITY; CELL COMPARTMENTALIZATION; CELL FREE SYSTEM; CHEMICAL MODIFICATION; CONFERENCE PAPER; DNA BINDING; EXON; GENE EXPRESSION REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; RNA TRANSLATION; TARGET CELL; TRYPANOSOMA;

ANIMALS; ANTIPROTOZOAL AGENTS; ANTIVIRAL AGENTS; DRUG DESIGN; EXONS; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, VIRAL; KINETOPLASTIDA; OLIGONUCLEOTIDES, ANTISENSE;

PROTOZOA; TRYPANOSOMA; TRYPANOSOMATIDAE;

EID: 0030883702     PISSN: 00311820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (113)

1. AGABIAN, N. (1990). Trans-splicing of nuclear pre-mRNAs. Cell 61, 1157-1160.
2. AGRAWAL, S. & TANG, J. Y. (1992). GEM* 91-An antisense oligonucleotide phosphorothioate as a therapeutic agent for AIDS. Antisense Research Development 2, 261-266.
3. BANGS, J. D., CRAIN, P. F., HASHIZUME, T., McCLOSKEY, J. A. & BOOTHROYD, J. C. (1992). Mass spectrometry of messenger RNA cap-4 from trypanosomatids reveals 2 novel nucleosides. Journal of Biological Chemistry 267, 9805-9815.
4. BARKER, R. H., METELEV, V., RAPAPORT, E. & ZAMECNIK, P. (1996) Inhibition of Plasmodium falciparum malaria using antisense oligonucleotides. Proceedings of the National Academy of Sciences, USA 93, 514-518.
5. BARRETT, J. C., MILLER, P. S. & TS'O, P. O. P. (1974). Inhibitory effect of complex formation with oligodeoxynucleotide ethyl phosphotriesters on transfer ribonucleic acid aminoacylation. Biochemistry 13, 4897-4906.
6. BARTOLOMÉ, J., MADEJON, A. & CARRENO, V. (1995). Ribozymes: structure, characteristics and use as potential antiviral agents. Journal of Hepatology 22, 57-64.
7. BEAUCAGE, S. L. & IYER, R. P. (1993). The synthesis of modified oligonucleotides by the phosphoramidite approach and their applications. Tetrahedron 49, 6123-6194.
8. BEKTESH, S., VAN DOREN, K. & HIRSH, D. (1988). Presence of the Caenorhabditis elegans spliced leader on different mRNAs and in different genera of nematodes. Genes & Development 2, 1227-1283.
9. BELIKOVA, A. M., ZARYTOVA, V. F. & GRINEVA, N. I. (1967). Synthesis of ribonucleosides and diribonucleoside phosphates containing 2-chloroethylamine and nitrogen mustard residues. Tetrahedron Letters 37, 3557-3562.
10. BERTRAND, J. R., IMBACH, J. L., PAOLETTI, C. & MALVY, C. (1989). Comparative activity of α- and β-anomeric oligonucleotides on rabbit β-globin synthesis: inhibitory effect of cap targeted α-oligonucleotides. Biochemistry and Biophysics Research Communications 164, 311-318.
11. BIELINSKA, A., SHIVDASANI, R. A., ZHANG, L. & NABEL, G. J. (1990). Regulation of gene expression with double-stranded phosphorothioate oligonucleotides. Science 250, 997-1000.
12. BOIZIAU, C., BOUTORINE, A. S., LOREAU, N., VERSPIEREN, P., THUONG, N. T. & TOULMÉ, J. J. (1991a). Effect of antisense oligonucleotides linked to alkylating agents on in vitro translation of rabbit β-globin and Trypanosoma brucei mRNAs. Nucleosides and Nucleotides 10, 239-244.
13. BOIZIAU, C., KURFURST, R., CAZENAVE, C., ROIG, V., THUONG, N. T. & TOULMÉ, J. J. (1991b). Inhibition of translation initiation by antisense oligonucleotides via an RNase-H independent mechanism. Nucleic Acids Research 19, 1113-1119.
14. BOIZIAU, C., LARROUY, B., SPROAT, B. & TOULMÉ, J. J. (1995). Antisense 2′-O-alkyl oligoribonucleotides are efficient inhibitors of reverse transcription. Nucleic Acids Research 23, 64-71.
15. BOIZIAU, C., THUONG, N. T. & TOULMÉ, J. J. (1992). Mechanisms of the inhibition of reverse transcription by antisense oligonucleotides. Proceedings of the National Academy of Sciences, USA 89, 768-772.
16. BORST, P. (1986). Discontinuous transcription and antigenic variation in trypanosomes. Annual Reviews of Biochemistry 55, 701-732.
17. BOUTORIN, A. S., GUSKOVA, L. V., IVANOVA, E. M., KOBETZ, N. D., ZARYTOVA, V. F., RYTE, A. S., YURCHENKO, L. V. & VLASSOV, V. V. (1989). Synthesis of alkylating oligonucleotide derivatives containing cholesterol or phenazidium residue at the 3′ termini and their interaction with DNA within mammalian cells. FEBS Letters 254, 129-132.
18. BROSSALINA, E., PASCOLO, E. & TOULMÉ, J. J. (1993). The binding of an antisense oligonucleotide to a hairpin structure via triplex formation inhibits chemical and biological reactions. Nucleic Acids Research 21, 5616-5622.
19. BROSSALINA, E. & TOULMÉ, J. J. (1993). A DNA hairpin as a target for antisense oligonucleotides. Journal of the American Chemical Society 115, 796-797.
20. BRUZIK, J. P., VAN DOREN, K., HIRSH, D. & STEITZ, J. A. (1988). Trans-splicing involves a novel form of small nuclear ribonucleoprotein particles. Nature 335, 559-562.
21. CAZENAVE, C., LOREAU, N., THUONG, N. T., TOULMÉ, J. J. & HÉLÈNE, C. (1987). Enzymatic amplification of translation inhibition of rabbit β-globin mRNA mediated by anti-messenger oligodeoxynucleotides covalently linked to intercalating agents. Nucleic Acids Research 15, 4717-4736.
22. CAZENAVE, C., STEIN, C. A., LOREAU, N., THUONG, N. T., NECKERS, L. M., SUBASINGHE, C., HÉLÈNE, C., COHEN, J. S. & TOULMÉ, J. J. (1989). Comparative inhibition of rabbit globin mRNA translation by modified antisense oligonucleotides. Nucleic Acids Research 17, 4255-4273.
23. CHIANG, M. Y., CHAN, H., ZOUNES, M. A., FREIER, S. M., LIMA, W. F. & BENNETT, C. F. (1991). Antisense oligonucleotides inhibit intercellular adhesion molecule-1 expression by two distinct mechanisms. Journal of Biological Chemistry 266, 18162-18171.
24. CHRISEY, L. A., PAZIRANDEH, M. & LISS, H. S. (1995). Nonsequence-specific inhibition of bacterial luminescence by phosphorothioate oligodeoxyribonucleotides. Antisense Research Developments 5, 261-269.
25. CLARK, D. L., CHRISEY, L. A., CAMPBELL, J. R. & DAVIDSON, E. A. (1994). Non-sequence-specific antimalarial activity of oligodeoxynucleotides. Molecular and Biochemical Parasitology 63, 129-134.
26. CLUSEL, C., UGARTE, E., ENJOLRAS, N., VASSEUR, M. & BLUMENFELD, M. (1993). Ex vivo regulation of specific gene expression by nanomolar concentration of double-stranded dumbbell oligonucleotides. Nucleic Acids Research 21, 3405-3411.
27. COHEN, J. S. (1991). Antisense oligodeoxynucleotides as antiviral agents. Antiviral Research 16, 121-133.
28. CORNELISSEN, A. W. C. A., VERSPIEREN, P., TOULMÉ, J. J., SWINKELS, B. W. & BORST, P. (1986). The common 5′ terminal sequence on trypanosome mRNAs: a target for anti-messenger oligodeoxynucleotides. Nucleic Acids Research 14, 5605-5614.
29. COWSERT, L. M. (1993). Antiviral activities of antisense oligonucleotides. In: Antisense Research and Applications (ed. Crooke, S. T. & Lebleu, B.), pp. 521-533, Boca Raton, CRC Press.
30. DAVIS, R. E., HARDWICK, C., TAVERNIER, P., HODGSON, S. & SINGH, H. (1995). RNA trans-splicing in flatworms Journal of Biological Chemistry 270, 21813-21819.
31. DAWSON, P. A., COCHRAN, D. A. E., EMMERSON, B. T., & GORDON, R. B. (1993). Inhibition of Plasmodium falciparum hypoxanthine-guanine phosphoribosyltransferase mRNA by antisense oligodeoxynucleotide sequence. Molecular and Biochemical Parasitology 60, 153-156.
32. DEGOLS, G., LÉONETTI, J. P., BENKIRANE, M., DEVAUX, C. & LEBLEU, B. (1992). Poly(L-Lysine)-conjugated oligonucleotides promote sequence-specific inhibition of acute HIV-1 infection. Antisense Research and Development 2, 293-301.
33. DOMINSKI, Z. & KOLE, R. (1993). Restoration of correct splicing in thalassemic pre-messenger RNA by antisense oligonucleotides. Proceedings of the National Academy of Sciences, USA 90, 8673-8677.
34. ELLINGTON, A. D. & CONRAD, R. (1995). Aptamers as potential nucleic acid pharmaceuticals. Biotechnology Annual Review. 1, 185-215.
35. FENNEWALD, S. M., MUSTAIN, S., OJWANG, J. & RANDO, R. F. (1995). Inhibition of herpes simplex virus in culture by oligonucleotides composed entirely of deoxyguanosine and thymidine. Antiviral Research 26, 37-54.
36. FREISTADT, M. S. (1988). Detection of a possible trans-splicing intermediate in Trypanosoma brucei. Nucleic Acids Research 16, 7720.
37. GABRIEL, A., SISODIA, S. S. & CLEVELAND, D. W. (1987). Evidence of discontinuous transcription in the trypanosomatid Crithidia fasciculata. Journal of Biological Chemistry 262, 16192-16199.
38. GAO, W., STEIN, C. A., COHEN, J. S., DUTSCHMAN, G. E. & CHENG, Y. C. (1989). Effect of phosphorothioate homooligodeoxynucleotides on herpes simplex virus type 2-induced DNA polymerase. Journal of Biological Chemistry 264, 11521-11526.
39. GAO, W. Y., HANES, R. N., VAZQUEZ-PADUA, M. A., STEIN, C. A., COHEN, J. S. & CHENG, Y. C. (1990). Inhibition of herpes simplex virus type 2 growth by phosphorothioate oligodeoxynucleotides. Antimicrobial Agents and Chemotherapy 34, 808-812.
40. GASPARRO, F. P., EDELSON, R. L., O'MALLEY, M. E., UGENT, S. J. & WONG, H. H. (1991). Photoactivatable antisense DNA: suppression of ampicillin resistance in normally resistant Escherichia coli. Antisense Research Developments 1, 117-140.
41. GILES, R. V., RUDDELL, C. J., SPILLER, D. G., GREEN, J. A. & TIDD, D. M. (1995). Single base discrimination for ribonuclease H-dependent antisense effects within intact human leukaemia cells. Nucleic Acids Research 23, 954-961.
42. GILES, R. V., SPILLER, D. G. & TIDD, D. M. (1995). Detection of ribonuclease H-generated mRNA fragments in human leukemia cells following reversible membrane permeabilization in the presence of antisense oligodeoxynucleotides. Antisense Research Developments 5, 23-31.
43. GILES, R. V. & TIDD, D. M. (1992). Increased specificity for antisense oligodeoxynucleotide targeting of RNA cleavage by RNase-H using chimeric methylphosphonodiester/phosphodiester structures. Nucleic Acids Research 20, 763-770.
44. GIOVANNANGELI, C., ROUGÉE, M., GARESTIER, T., THUONG, N. T. & HÉLÈNE, C. (1992). Triple-helix formation by oligonucleotides containing the 3 bases thymine, cytosine, and guanine. Proceedings of the National Academy of Sciences, USA 89, 8631-8635.
45. GOLD, L., POLISKY, B., UHLENBECK, O. & YARUS, M. (1995). Diversity of oligonucleotide functions. Annual Review of Biochemistry 64, 763-797.
46. HARRIS, K. A., CROTHERS, D. M. & ULLU, E. (1995). In vivo structural analysis of spliced leader RNAs in Trypanosoma brucei and Leptomonas collosoma: a flexible structure that is dependent of cap4 methylations. RNA 1, 351-362.
47. HÉLÈNE, C. & TOULMÉ, J. J. (1989). Control of gene expression by oligodeoxynucleotides covalently linked to intercalating agents and nucleic acid cleaving reagents. In: Oligodeoxynucleotides : Antisense Inhibitors of Gene Expression (ed. Cohen, J. S.), pp. 137-172, London, Macmillan Press.
48. HEacute;LÈNE, C. & TOULMÉ, J. J. (1990). Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochimica et Biophysica Acta. 1049, 99-125.
49. JAYARAMAN, K., McPARLAND, K., MILLER, P. & TS'O, P. O. P. (1981). Selective inhibition of Escherichia coli protein synthesis and growth by nonionic oligonucleotides complementary to the 3′ end of 16S rRNA. Proceedings of the National Academy of Sciences, USA 78, 1537-1541.
50. JOHANSSON, H. E., BELSHAM, G. J., SPROAT, B. S. & HENTZE, M. W. (1994). Target-specific arrest of mRNA translation by antisense 2′-O-alkyloligoribonucleotides. Nucleic Acids Research 22, 4591-4598.
51. KULKA, M., SMITH, C. C., AURELIAN, L., FISHELEVICH, R., MEADE, K., MILLER, P. & TS'O, P. O. P. (1989). Site specificity of the inhibitory effects of oligo(nucleosidemethylphosphonate)s complementary to the acceptor splice junction of herpes simplex virus type I immediate early mRNA 4. Proceedings of the National Academy of Sciences, USA 86, 6868-6872.
52. KULKA, M., WACHSMAN, M., MIURA, S., FISHELEVICH, R., MILLER, P. S., TS'O, P. O. P. & AURELIAN, L. (1993). Antiviral effect of oligo(nucleoside methylphosphonates) complementary to the herpes simplex virus type 1 immediate early mRNAs 4 and 5. Antiviral Research 20, 115-130.
53. KUMAR, P. K. R. & ELLINGTON, A. D. (1995). Artificial evolution and natural ribozymes. FASEB Journal 9, 1183-1195.
54. LAIRD, P. W. (1989). Trans-splicing in trypanosomesarchaism or adaptation? TIG. 5, 204-208.
55. LARROUY, B., BLONSKI, C., BOIZIAU, C., STUER, M., MOREAU, S., SHIRE, D. & TOULMÉ, J. J. (1992). RNase-H mediated inhibition of translation by antisense oligodeoxynucleotides: a way to improve specificity. Gene 121, 189-194.
56. LARROUY, B., BOIZIAU, C., SPROAT, B. & TOULMÉ, J. J. (1995). High affinity or selectivity: a dilemma to design antisense oligodeoxynucleotides acting in RNaseH-containing media. Nucleic Acids Research 23, 3434-3440.
57. LECUYER, K. & CROTHERS, D. M. (1993). The Leptomonas collosoma spliced leader RNA can switch between two alternate structural forms. Biochemistry 32, 5301-5311.
58. LEMAÎTRE, M., BAYARD, B. & LEBLEU, B. (1987). Specific antiviral activity of a poly(L-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site. Proceedings of the National Academy of Sciences, USA 84, 648-652.
59. LÉONETTI, J. P., DEGOLS, G., CLARENC, J. P., MECHTI, N. & LEBLEU, B. (1993). Cell delivery and mechanisms of action of antisense oligonucleotides. In: Progress in Nucleic Acid Research and Molecular Biology (ed. Cohn, W. E. & Moldave, K.), pp. 143-166, San Diego, CA, Academic Press Inc.
60. MAJUMDAR, C., STEIN, C. A., COHEN, J. S., BRODER, S. & WILSON, S. H. (1989). Stepwise mechanism of HIV reverse transcriptase: primer function of phosphorothioate oligodeoxynucleotide. Biochemistry. 28, 1340-1346.
61. MATSUKURA, M., SHINOKUZA, K., ZON, G., MITSUYA, H., REITZ, M., COHEN, J. S. & BRODER, S. (1987). Phosphorotioate analogues of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus. Proceedings of the National Academy of Sciences, USA 84, 7706-7710.
62. MATSUKURA, M., ZON, G., SHINOZUKA, K., ROBERT-GUROFF, M., SHIMADA, T., STEIN, C. A., MITSUYA, H., WONG-STAAL, F., COHEN, J. S. & BRODER, S. (1989). Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells. Proceedings of the National Academy of Sciences, USA 86, 4244-4248.
63. MICHEL, J., TOULMÉ, J. J., VERCAUTEREN, J. & MOREAU, S. (1995). Quinazoline-2,4(1H, 3H)-dione as a substitute for thymine in triple-helix forming oligonucleotides: a reassessment. Nucleic Acids Research 24, 1127-1135.
64. MILLER, P. S., BRAITERMAN, L. T. & TS'O, P. O. P. (1977). Effects of a trinucleotide ethyl phosphotriester, Gmp(Et)Gmp(Et)U on mammalian cells in culture. Biochemistry 16, 1988-1996.
65. MILLIGAN, J. F., MATTEUCCI, M. D. & MARTIN, J. C. (1993). Current concepts in antisense drug design. Journal of Medicinal Chemistry 36, 1923-1937.
66. MISHRA, R. K., LE TINÉVEZ, R. & TOULMÉ, J. J. (1996). Targeting nucleic acid secondary structures by antisense oligonucleotides designed through in vitro selection. Proceedings of the National Academy of Sciences, USA 93, 10679-10684.
67. MISHRA, R. K., MOREAU, C., RAMAZEILLES, C., MOREAU, S., BONNET, J. & TOULMÉ, J. J. (1995). Improved leishmanicidal effect of phosphorothioate antisense oligonucleotides by LDL-mediated delivery. Biochimica et Biophystca Acta. 1264, 229-237.
68. MISHRA, R. K. & TOULMÉ, J. J. (1994). In vitro selection of antisense oligonucleotides targeted to a hairpin structure. Compte Rendu de l'Academie des Sciences, Paris. 317, 977-982.
69. NILSEN, T. W. (1993). Trans-splicing of nematode premessenger RNA. Annual Reviews of Microbiology 47, 413-440.
70. OFFENSPERGER, W. B., OFFENSPERGER, S., WALTER, E., TEUBNER, K., IGLOI, G., BLUM, H. E. & GEROK, W. (1993). In vivo inhibition of duck hepatitis-B virus replication and gene expression by phosphorothioate modified antisense oligodeoxynucleotides. EMBO Journal 12, 1257-1262.
71. PASCOLO, E., BLONSKI, C., SHIRE, D. & TOULMÉ, J.-J. (1993). Antisense effect of oligodeoxynucleotides complementary to the mini-exon sequence of the protozoan parasite Leishmania amazonensis. Biochimie 75, 43-47.
72. PASCOLO, E., HUDRISIER, D., SPROAT, B., THUONG, N. T. & TOULMÉ, J.-J. (1994). Relative contribution of photoaddition, helper oligonucleotide and RNase H to the antisense effect of psoralen-oligonucleotide conjugates, on in vitro translation of Leishmania mRNAs. Biochimica et Biophysica Acta. 1219, 98-106.
73. PASCOLO, E. & TOULMÉ, J.-J. (1996). Double hairpin complexes allow to accomodate all four base pairs in triple helices containing both DNA and RNA strands. Journal of Biological Chemistry 271, 24187-24192.
74. PERRY, K. L., WATKINS, K. P. & AGABIAN, N. (1987). Trypanosome mRNAs have unusual cap 4 structures acquired by addition of a spliced leader. Proceedings of the National Academy of Sciences, USA 84, 8190-8194.
75. RAHMAN, M. A., SUMMERTON, J., FOSTER, E., CUNNINGHAM, K., STIRCHAK, E., WELLER, D. & SCHAUP, H. W. (1991). Antibacterial activity and inhibition of protein synthesis in Escherichia coli by antisense DNA analogs. Antisense Research and Development 1, 319-327.
76. RAMASAMY, R., KANAGARATNAM, R., MISIURA, K., REBOWSKI, G., AMERAKOON, R. & STEC, W. J. (1996). Anti-sense oligonucleoside phosphorothioates nonspecifically inhibit invasion of red blood cells by malaria parasites. Biochemistry and Biophysics Research Communications 218, 930-933.
77. RAMAZEILLES, C., MISHRA, R. K., MOREAU, S., PASCOLO, E. & TOULMÉ, J. J. (1994). Antisense phosphorothioate oligonucleotides: selective killing of the intracellular parasite Leishmania amazonensis. Proceedings of the National Academy of Sciences, USA 91, 7859-7863.
78. RAPAPORT, E., LEVINA, V., METELEV, V. & ZAMECNIK, P. C. (1996). Antimycobacterial activities of antisense oligodeoxynucleotide phosphorothioates in drug-resistant strains. Proceedings of the National Academy of Sciences, USA 93, 709-713.
79. RAPAPORT, E., MISIURA, K., AGRAWAL, S. & ZAMECNIK, P. (1992). Antimalarial activities of oligodeoxynucleotide phosphorothioates in chloroquine-resistant Plasmodium falciparum. Proceedings of the National Academy of Sciences, USA 89, 8577-8580.
80. ROPERT, C., MALVY, C. & COUVREUR, P. (1993). Inhibition of the Friend retrovirus by antisense oligonucleotides encapsulated in liposomes - mechanism of action. Pharmaceutical Research 10, 1427-1433.
81. ROPERT, C., MISHAL, Z., RODRIGUES, J. M., MALVY, C. & COUVREUR, P. (1996). Retrovirus budding may constitute a port of entry for drug carriers. Biochimica et Biophysica Acta 1310, 53-59.
82. SARTORIUS, C. & FRANKLIN, R. M. (1991). Hybridization arrest of the cell-free translation of the malarial dihydrofolate reductase/thymidylate synthase messenger RNA by anti-sense oligodeoxyribonucleotides. Nucleic Acids Research 19, 1613-1618.
83. STEIN, C. A., NECKERS, L. M., NAIR, B. C., MUMBAUER, S., HOKE, G. & PAL, R. (1991). Phosphorothioate oligodeoxycytidine interferes with binding of HIV-1 gp120 to CD4. Journal of Acquired Immune Deficiency Syndrome 4, 686-693.
84. STEPHENSON, M. L. & ZAMECNIK, P. C. (1978). Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide. Proceedings of the National Academy of Sciences, USA 75, 285-288.
85. SYMONS, R. H. (1992). Small catalytic RNAs. Annual Review of Biochemistry 61, 641-671.
86. TESSIER, L. H., KELLER, M., CHAN, R. L., FOURNIER, R., WEIL, J. H. & IMBAULT, P. (1991). Short leader sequences may be transferred from small RNAs to pre-mature messenger RNAs by trans-splicing in Euglena. EMBO Journal 10, 2621-2625.
87. THUONG, N. T. & HÉLÈNE, C. (1993). Sequence specific recognition and modification of double-helical DNA by oligonucleotides. Angew. Chem. Int. Ed. Engl. 32, 666-690.
88. TO, R. Y. (1992). Antisense control of retrovirus replication and gene expression. In: Antisense RNA and DNA (ed. Murray, J. A. H.), pp. 267-284, New York, Wiley-Liss.
89. TOULMÉ, J. J., LE TINÉVEZ, R. & BROSSALINA, E. (1996). Targeting RNA structures by antisense oligonucleotides. Biochimie 78, 663-673.
90. TOULMÉ, J. J. & TIDD, D. (1997). Role of ribonuclease H in antisense oligonucleotide-mediated effects. In: Ribonucleases H (ed. Crouch, R. J., & Toulmé, J. J.), pp. In press, Paris, John Libbey.
91. TOULMÉ, J. J., VERSPIEREN, P., BOIZIAU, C., LOREAU, N., CAZENAVE, C. & THUONG, N. T. (1990a). Les oligonucléotides antisens: outils de génétique moléculaire et agents thérapeutiques. Annales de Parasitologie Humaine et Comparée 65, Supp. I, 11-14.
92. TOULMÉ, J. J., VERSPIEREN, P., THUONG, N. T., LOREAU, N., CAZENAVE, C. & BOIZIAU, C. (1990b). Antisense oligonucleotides as anti-parasitic agents. In: Chemotherapy for Trypanosomiasis. (ed. Peregrine, A. S.), pp. 137-144, Nairobi, ILRAD.
93. TSCHUDI, C. & ULLU, E. (1990). Destruction of U2, U4, or U6 small nuclear RNA blocks trans splicing in trypanosome cells. Cell 61, 459-466.
94. ULLU, E. & TSCHUDI, C. (1991). Trans-splicing in trypanosomes requires methylation of the 5′ end of the spliced leader RNA. Proceedings of the National Academy of Sciences, USA 88, 10074-10078.
95. ULLU, E. & TSCHUDI, C. (1993). 2′-O-methyl RNA oligonucleotides identify 2 functional elements in the trypanosome spliced leader ribonucleoprotein particle. Journal of Biological Chemistry 268, 13068-13073.
96. ULLU, E. & TSCHUDI, C. (1995). Accurate modification of the trypanosome spliced leader cap structure in a homologous cell-free system. Journal of Biological Chemistry 270, 20365-20369.
97. VERSPIEREN, P., CORNELISSEN, A. W. C. A., THUONG, N. T., HÉLÈNE, C. & TOULMÉ, J. J. (1987). An acridine-linked-oligodeoxynucleotide targeted to the common 5′ end of trypanosome mRNAs kills cultured parasites. Gene 61, 307-315.
98. VERSPIEREN, P., LOREAU, N., THUONG, N. T., SHIRE, D. & TOULMÉ, J. J. (1990). Effect of RNA secondary structure and modified bases on the in vitro inhibition of trypanosomatid protein synthesis by antisense oligodeoxynucleotides. Nucleic Acids Research 18, 4711-4717.
99. VERSPIEREN, P., THUONG, N. T., HÉLÈNE, C. & TOULMÉ, J. J. (1988). Antisense oligodeoxynucleotides as regulatory agents for trypanosome genes. In: Antisense RNA and DNA (ed. Melton, D.), pp. 53-60, Cold Spring Harbor, USA, Cold Spring Harbor Laboratory Press.
100. VICKERS, T., BAKER, F., COOK, P. D., ZOUNES, M., BUCKHEIT, R. W., GERMANY, J. & ECKER, D. J. (1991). Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR element. Nucleic Acids Research 19, 3359-3368.
101. VLASSOV, V. V., BALAKIREVA, L. A. & YAKUBOV, L. A. (1994). Transport of oligonucleotides across natural and model membranes. Biochimica et Biophysica Acta. 1197, 95-108.
102. VOLKMANN, S., JENDIS, J., FRAUENDORF, A. & MOELLING, K. (1995). Inhibition of HIV-1 reverse transcription by triple-helix forming oligonucleotides with viral RNA. Nucleic Acids Research 23, 1204-1212.
103. WAGNER, R. W., MATTEUCCI, M. D., LEWIS, J. G., GUTIERREZ, A. J., MOULDS, C. & FROEHLER, B. C. (1993). Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines. Science 260, 1510-1513.
104. WALDER, J. A., EDER, P. S., ENGMAN, D. M., BRENTANO, S. T., WALDER, R. Y., KNUTZON, D. S., DORFMAN, D. M. & DONELSON, J. E. (1986). The 35-nucleotide spliced leader sequence is common to all trypanosome messenger RNA. Science 233, 569-571.
105. WALDER, R. Y. & WALDER, J. A. (1988). Role of RNase-H in hybrid-arrested translation by antisense oligonucleotides. Proceedings of the National Academy of Sciences, USA 85, 5011-5015.
106. WHITTON, J. L. (1994). Antisense treatment of viral infection. In: Advances in Virus Research, Vol 44 (ed. Maramorosch, K., Murphy, F. A. & Shatkin, A. J.), pp. 267-303, San Diego, CA, Academic Press Inc.
107. WOO, J., MEYER, R. & GAMPER, H. B. (1996). G/C-modified oligonucleotides with selective complementarity: synthesis and hybridization properties. Nucleic Acids Research 24, 2470-2475.
108. WYATT, J. R., VICKERS, T. A., ROBERSON, J. L., BUCKHEIT, R. W., Jr., KLIMKAIT, T., DEBAETS, E., DAVIS, P. W., RAYNER, B., IMBACH, J. L. & ECKER, D. J. (1994). Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion. Proceedings of the National Academy of Sciences, USA 91, 1356-1360.
109. XODO, L. E., MANZINI, G., QUADRIFOGLIO, F., VANDERMAREL, G. A. & VANBOOM, J. H. (1991). Effect of 5-methylcytosine on the stability of triple-stranded DNA - a thermodynamic study Nucleic Acids Research 19, 5625-5631.
110. ZAMECNIK, P. C. & STEPHENSON, M. L. (1978). Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proceedings of the National Academy of Sciences, USA 75, 280-284.
111. ZELPHATI, O., IMBACH, J. L., SIGNORET, N., ZON, G., RAYNER, B. & LESERMAN, L. (1994). Antisense oligonucleotides in solution or encapsulated in immunoliposomes inhibit replication of HIV-1 by several different mechanisms. Nucleic Acids Research 22, 4307-4314.
112. ZERIAL, A., THUONG, N. T. & HÉLÈNE, C. (1987). Selective inhibition of cytopathic effect of type A influenza viruses by oligodeoxynucleotides covalently linked to an intercalating agent. Nucleic Acids Research 15, 9909-9919.
113. ZON, G. (1995). Brief overview of control of genetic expression by antisense oligonucleotides and in vivo applications - prospects for neurobiology. Molecular Neurobiology 10, 219-229.